Professor, University of Alberta Medical oncologist and Clinical pharmacologist, Cross Cancer Institute of Alberta Health Services Edmonton, AB, USA
Dr. Michael Sawyer is a Professor in the Department of Oncology of the University of Alberta, and a medical oncologist and clinical pharmacologist for the Cross Cancer Institute of Alberta Health Services. He obtained his Bachelor of Science in Pharmacy and his MD from the University of Toronto. He completed his fellowship in Medical Oncology fellowship at the University of Western Ontario and completed his training in drug development and Clinical Pharmacology at the University of Chicago Cancer Center. The focus of his research is on causes of inter-patient variability in terms of both toxicity and efficacy to cancer chemotherapy. His research program centers on three fields of study: 1) nucleoside transporters 2) tyrosine kinase inhibitor pharmacology and 3) body composition of cancer patients. He is also the head of the Phase I program at the Cross Cancer Institute.